Tris Pharma has reported positive outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol to treat moderate-to-severe ...
The US company said that results from the Alpha-CORRECT trial saw its colon cancer diagnostic Oncodetect achieving a ...
Clinical research company Advarra has introduced Study Collaboration, a solution designed to expedite study startup by ...
The US FDA has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's consumer healthcare business, Opella.
The trial is seeking to examine SalubrisBio’s JK07, a recombinant antibody fusion protein designed to produce regenerative effects on the heart through signalling interactions with two different ...
Amylyx will be allowed to run a Phase I trial after the FDA lifted a clinical hold of its investigational ALS drug.
Synthetic chemicals called per- and polyfluoroalkyl substances (PFAS) have been accumulating in the environment since their ...
Ascletis Pharma has reported positive topline outcomes from its US Phase Ia SAD study of the oral tablet, ASC30, in obese ...
In the complex field of clinical trials, the ability to harness robust marketing and sales intelligence is not just an advantage. It is now a critical component of any business ecosystem. As the ...
Valneva has announced positive outcomes from its Phase III trial of the single-shot IXCHIQ chikungunya virus vaccine in ...
YolTech Therapeutics is set to commence a trial of its in vivo gene editing therapy, YOLT-204, aimed at treating TDT.
The Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognize the people and companies that are driving change. Our program ...